India's Alkem Labs denies its products failed quality test

Alkem Laboratories

27/09/2024 15:40

BENGALURU, Sept 27 (Reuters) - India's Alkem
Laboratories  ALKE.NS  on Friday denied claims that batches of
its products, Pan-D and Clavam 625, are not of standard quality
as the country's drug regulator flagged, adding that those
samples were fake.
    India's drug regulator, which releases a monthly list of
substandard or fake medicines sold in the country, said it found
more than 50 drugs, including some batches of widely used
antacids and paracetamol, "not of standard quality".     
    Alkem said it investigated the claims by comparing the
Central Drugs Standard Control Organisation's samples and the
actual batches of both products and found that the CDSCO's
samples were not manufactured by the company.
    The shares of the company slipped more than 1% before
closing 0.2% lower on Friday.
    

 (Reporting by Ashna Teresa Britto; Editing by Janane
Venkatraman)
 ((AshnaTeresa.Britto@thomsonreuters.com;))